# Avian Chlamydiosis and Aspergillosis ## Quick Answer - Select PCR on conjunctival or choanal swabs for acute avian chlamydiosis, as it detects active shedding with high sensitivity. - For aspergillosis, combine serology with radiography and culture, since no single test confirms infection across all clinical stages. - Both diseases require veterinary interpretation because test sensitivity varies with chronicity, sample quality, and prior antimicrobial therapy. ## Understanding Avian Chlamydiosis and Aspergillosis Avian chlamydiosis and aspergillosis represent two of the most clinically significant infectious diseases affecting companion birds, poultry, and captive avian collections. Both conditions produce respiratory signs that overlap with many other avian diseases, making diagnostic testing essential for appropriate case management. The [Merck Veterinary Manual](https://www.merckvetmanual.com/) provides authoritative background on both diseases, including their etiologic agents, transmission patterns, and clinical presentations. Avian chlamydiosis, caused by the bacterium *Chlamydia psittaci*, is a zoonotic disease that affects psittacine birds most commonly but can infect over 460 bird species. The organism is an obligate intracellular bacterium that targets respiratory epithelium and macrophages. Infected birds shed the organism through respiratory secretions and feces, creating transmission risk for both other birds and humans. The zoonotic potential of this disease makes accurate diagnosis a public health priority, also a clinical exercise. Aspergillosis, in contrast, is caused by saprophytic fungi of the genus *Aspergillus*, most commonly *Aspergillus fumigatus*. These fungi are ubiquitous in the environment and become pathogenic when birds are immunocompromised, stressed, or exposed to high spore concentrations. The disease typically manifests as either an acute respiratory form or a chronic granulomatous form, with the chronic form being more common in captive birds. The diagnostic approach differs substantially between these two presentations. Both diseases share overlapping clinical signs including dyspnea, lethargy, weight loss, and abnormal respiratory sounds. This clinical overlap creates a diagnostic challenge for veterinarians who must differentiate between bacterial and fungal etiologies to select appropriate therapy. The diagnostic testing landscape for both diseases has evolved considerably, with molecular methods now complementing traditional serology and culture techniques. The [World Organisation for Animal Health](https://www.woah.org/en/what-we-do/animal-health-and-welfare) provides official guidance on animal health surveillance and reporting, which is particularly relevant for avian chlamydiosis given its reportable status in many jurisdictions. Veterinarians should be aware of local reporting requirements when they suspect this disease. ## At a Glance The following table summarizes the primary diagnostic testing options for avian chlamydiosis and aspergillosis, including sample types and key considerations for test selection. | Test Method | Disease | Sample Type | Key Considerations | |-------------|---------|-------------|-------------------| | PCR | Chlamydiosis | Conjunctival, choanal, or cloacal swabs | High sensitivity in acute shedding, detects DNA but does not distinguish viable from nonviable organisms | | Serology | Chlamydiosis | Serum or plasma | Detects antibodies from prior exposure, useful for chronic or latent infections | | Antigen detection | Chlamydiosis | Fecal or respiratory samples | Rapid results but lower sensitivity than PCR, may miss low-level shedding | | PCR | Aspergillosis | Tracheal wash, air sac aspirate, or tissue biopsy | Confirms fungal DNA presence, invasive sample collection required | | Serology | Aspergillosis | Serum | Antibody detection supports exposure but does not confirm active infection | | Galactomannan antigen | Aspergillosis | Serum | Detects fungal cell wall component, useful for chronic cases but sensitivity varies | ## Clinical Presentation and Diagnostic Challenges ### Recognizing Clinical Signs Avian chlamydiosis presents with a range of clinical signs that vary with the species affected, the strain of the organism, and the stage of infection. Acute infections in psittacine birds often produce conjunctivitis, rhinitis, dyspnea, and diarrhea. The classic presentation includes bilateral conjunctivitis with serous or mucopurulent ocular discharge, which may be accompanied by sneezing and nasal discharge. Systemic signs include lethargy, anorexia, and weight loss. Some birds develop hepatomegaly or splenomegaly, which may be detected on physical examination or imaging. Aspergillosis presents differently depending on whether the infection is acute or chronic. Acute aspergillosis typically affects young birds or those with heavy environmental exposure to fungal spores. These birds show severe respiratory distress, open-mouth breathing, and cyanosis. The chronic form, which is more common in older birds, presents with weight loss, voice change, dyspnea, and exercise intolerance. Granulomas may form in the air sacs, lungs, or trachea, leading to partial airway obstruction. The overlap in clinical signs between these two diseases and other respiratory conditions means that diagnostic testing is essential. A bird presenting with respiratory signs could have chlamydiosis, aspergillosis, bacterial pneumonia, mycoplasmosis, or a foreign body in the airway. The diagnostic approach must therefore be systematic and include multiple testing modalities. ### Differentiating Features Several clinical features help differentiate these diseases. Chlamydiosis often presents with conjunctivitis, which is less common in aspergillosis. The onset of chlamydiosis is typically more acute, while chronic aspergillosis develops over weeks to months. Birds with chlamydiosis may show improvement with appropriate antibiotic therapy, while birds with aspergillosis require antifungal treatment. The species affected also provides diagnostic clues. Chlamydiosis is more common in psittacine birds, particularly cockatiels, budgerigars, and Amazon parrots. Aspergillosis is more common in waterfowl, raptors, and penguins, although it can affect any avian species. The environment also matters, as birds housed in damp, poorly ventilated conditions are at higher risk for aspergillosis. ## Diagnostic Testing for Avian Chlamydiosis ### PCR Testing Polymerase chain reaction testing has become the preferred diagnostic method for avian chlamydiosis in many clinical settings. PCR detects the DNA of *Chlamydia psittaci* directly from clinical samples, providing high sensitivity and specificity. The test can be performed on conjunctival, choanal, cloacal, or tracheal swabs, with conjunctival and choanal swabs generally providing the highest yield in actively shedding birds. The sensitivity of PCR testing depends on several factors, including the stage of infection, the sample type, and the quality of the sample collection. Birds that are actively shedding the organism are more likely to test positive by PCR than birds with latent infections. The test detects DNA from both viable and nonviable organisms, which means a positive PCR result does not necessarily indicate an active infection. This limitation requires clinical correlation with the bird's signs and history. PCR testing is particularly useful for confirming infection in birds with clinical signs consistent with chlamydiosis. The test can provide results within 24 to 48 hours, allowing for prompt treatment decisions. However, the test requires specialized laboratory equipment and trained personnel, which may limit its availability in some settings. ### Serology Testing Serologic testing for avian chlamydiosis detects antibodies produced by the bird's immune system in response to infection. The most commonly used serologic tests include elementary body agglutination, indirect immunofluorescence, and enzyme-linked immunosorbent assay. These tests detect antibodies that appear after infection and can persist for months or years. Serology is most useful for detecting chronic or latent infections, where the organism may not be actively shedding. A positive serologic test indicates that the bird has been exposed to the organism at some point, but it does not confirm an active infection. A negative serologic test does not rule out infection, particularly in the early stages of disease when antibodies have not yet developed. The timing of serologic testing is important. Antibodies typically appear within 7 to 14 days after infection, so testing too early may produce a false negative result. A second test performed 2 to 4 weeks later can confirm seroconversion. Paired serology, where two samples are collected at different time points, provides the most reliable serologic diagnosis. ### Antigen Detection Testing Antigen detection tests identify components of the *Chlamydia psittaci* organism directly in clinical samples. These tests include enzyme-linked immunosorbent assays and direct fluorescent antibody tests. Antigen tests provide rapid results, often within hours, and can be performed in a clinical setting without specialized laboratory equipment. The sensitivity of antigen tests is generally lower than PCR, particularly in birds with low levels of shedding. The tests may produce false negative results in birds with chronic or latent infections. The specificity of antigen tests is generally high, but cross-reactions with other organisms can occur. Antigen testing is most useful for screening birds in quarantine or for confirming infection in birds with clinical signs consistent with chlamydiosis. The test is less useful for monitoring treatment response, as the antigen may persist after the organism is no longer viable. ### Culture Testing Culture of *Chlamydia psittaci* is the traditional gold standard for diagnosis, but it is rarely used in clinical practice due to its technical difficulty and the biosafety concerns associated with handling the organism. The organism requires cell culture for isolation, which is time-consuming and requires specialized laboratory facilities. Culture is also less sensitive than PCR, as the organism may not survive transport or may be present in low numbers. Culture is primarily used in research settings or for epidemiologic investigations where strain characterization is needed. The test is not recommended for routine diagnostic use in clinical practice. ## Diagnostic Testing for Aspergillosis ### Serology Testing Serologic testing for aspergillosis detects antibodies against *Aspergillus* species in the serum. The most commonly used tests include agar gel immunodiffusion, enzyme-linked immunosorbent assay, and immunoblotting. These tests detect antibodies that develop in response to infection, which typically appear 2 to 4 weeks after exposure. Serology is most useful for the diagnosis of chronic aspergillosis, where the bird has been infected for weeks or months. The test is less useful for acute infections, where antibodies have not yet developed. A positive serologic test supports the diagnosis of aspergillosis, but it does not confirm the presence of active infection. A negative serologic test does not rule out the disease, particularly in the early stages of infection. The sensitivity of serology for aspergillosis varies with the stage of the disease. In chronic cases, the sensitivity is relatively high, with most infected birds showing detectable antibodies. In acute cases, the sensitivity is lower, and the test may produce false negative results. The specificity of serology is generally good, but cross-reactions with other fungal species can occur. ### Antigen Testing Antigen testing for aspergillosis detects components of the fungal cell wall, particularly galactomannan, in the blood. The galactomannan antigen test is used in human medicine and has been adapted for avian species. The test is most useful for the diagnosis of invasive aspergillosis, where the fungus is actively growing in tissues. The sensitivity of the galactomannan antigen test varies with the species and the stage of the disease. The test is more sensitive in birds with acute invasive disease than in birds with chronic granulomatous disease. The test can produce false positive results in birds that have been exposed to certain antibiotics or other substances that cross-react with the test. The galactomannan antigen test is not widely available for avian species and may require submission to a specialized laboratory. The test is most useful when combined with other diagnostic modalities, such as radiography and serology. ### PCR Testing PCR testing for aspergillosis detects the DNA of *Aspergillus* species in clinical samples. The test can be performed on tracheal washes, air sac swabs, or blood samples. The test provides high sensitivity and specificity, but the sample collection is more invasive than for chlamydiosis. The PCR test is most useful for confirming the diagnosis of aspergillosis in birds with clinical signs and radiographic changes consistent with the disease. The test can also be used to monitor the response to treatment, as the DNA should become undetectable with successful therapy. The sensitivity of PCR for aspergillosis varies with the sample type and the stage of the disease. The test is more sensitive in birds with active fungal growth than in birds with chronic granulomatous disease. The test can produce false negative results if the sample does not contain fungal DNA, which can occur if the lesion is not sampled. ### Culture Testing Culture of *Aspergillus* species from clinical samples is a traditional diagnostic method. The fungus grows readily on standard fungal culture media, and the identification of the species is based on the morphology of the fungal colony and the microscopic appearance of the spores. Culture is most useful for the diagnosis of aspergillosis when the fungus is present in the respiratory tract or in a granuloma. The test is less sensitive than PCR, as the fungus may not be present in the sample or may be overgrown by other organisms. The culture can also be contaminated with environmental fungi, which can complicate the interpretation. Culture is useful for the identification of the specific species of *Aspergillus* and for antifungal susceptibility testing. The test is not useful for the diagnosis of chronic aspergillosis, where the fungus may be present in low numbers or in a nonviable state. ## Sample Collection and Handling ### Sample Types for Chlamydiosis The choice of sample type for chlamydiosis testing depends on the clinical presentation and the stage of the disease. Conjunctival swabs are the most sensitive sample type for birds with conjunctivitis, as the organism is present in the conjunctival tissue. Choanal swabs are useful for birds with respiratory signs, as the organism is present in the respiratory tract. Cloacal swabs are useful for birds with gastrointestinal signs, but the sensitivity is lower than for conjunctival or choanal swabs. The sample collection technique is important for the accuracy of the test. The swab should be inserted into the conjunctival sac or the choanal cleft and rotated to collect cells. The swab should be placed in a transport medium appropriate for the test being performed. For PCR, the swab should be placed in a sterile tube without transport medium, as the medium may interfere with the PCR reaction. The timing of the sample collection is also important. The organism is shed in the highest numbers during the acute phase of the infection. The sample should be collected before the initiation of antibiotic therapy, as antibiotics can reduce the shedding of the organism and cause false negative results. ### Sample Types for Aspergillosis The sample types for aspergillosis testing depend on the clinical presentation and the diagnostic test. For serology, a blood sample is collected and the serum is separated. For PCR, a tracheal wash, air sac swab, or blood sample can be used. The tracheal wash is collected by passing a catheter through the trachea and flushing with sterile saline. The air sac swab is collected by inserting a swab through the air sac. The sample collection for aspergillosis is more invasive than for chlamydiosis, and the procedure may require sedation or anesthesia. The sample should be collected before the initiation of antifungal therapy, as the therapy can reduce the fungal load and cause false negatives. The handling of the sample is important for the accuracy of the test. The sample should be transported to the laboratory as soon as possible, and the sample should be kept at the appropriate temperature. The PCR sample should be kept at room temperature or refrigerated, and the serum sample should be kept refrigerated or frozen. ## Test Selection Based on Clinical Presentation ### Acute Respiratory Disease For a bird presenting with acute respiratory signs, the diagnostic approach should prioritize the detection of the organism. PCR on conjunctival or choanal swabs is the preferred test for chlamydiosis, as it provides the highest sensitivity for active shedding. The test should be performed before the initiation of antibiotic therapy. For aspergillosis, the acute presentation is less common, but the PCR on a tracheal wash or air sac swab can be useful. The galactomannan antigen test can also be useful for the diagnosis of invasive aspergillosis. The serology is less useful for the acute presentation, as the antibody response has not yet developed. ### Chronic Respiratory Disease For a bird with chronic respiratory disease, the diagnostic approach should include both serology and PCR. The serology is useful for the detection of chronic chlamydiosis, where the antibody is present. The PCR is useful for the detection of the organism in the respiratory tract. For aspergillosis, the serology is the most useful test for the chronic form of the disease. The antibody is present in the serum, and the test can confirm the diagnosis. The PCR can be useful for the detection of the fungal DNA in the respiratory tract, but the sensitivity is lower in the chronic form. ### Subclinical Infection For a bird with a subclinical infection, the diagnosis is more challenging. The PCR may be negative, as the organism is not actively shedding. The serology may be positive, indicating prior exposure, but the test does not confirm an active infection. The diagnosis of a subclinical infection requires a combination of the clinical history, the serology, and the PCR. ## Practical Implementation Steps ### Step 1: Assess the Clinical Presentation The first step in the diagnostic approach is to assess the clinical presentation of the bird. The history should include the species, the age, the environment, and the duration of the clinical signs. The physical examination should include the respiratory rate, the respiratory effort, and the presence of the discharge. ### Step 2: Select the Diagnostic Test The selection of the diagnostic test should be based on the clinical presentation and the suspected disease. For a bird with acute respiratory signs, the PCR on the conjunctival or choanal swab is the preferred test for chlamydiosis. For a bird with chronic respiratory signs, the serology is the preferred test for aspergillosis. ### Step 3: Collect the Sample The sample collection should be performed using the appropriate technique for the test. The sample should be collected before the initiation of the therapy. The sample should be transported to the laboratory as soon as possible. ### Step 4: Interpret the Results The interpretation of the test results should be based on the clinical presentation and the test characteristics. A positive PCR result confirms the presence of the organism, but it does not confirm the active infection. A positive serology result indicates the exposure to the organism, but it does not confirm the active infection. ### Step 5: Confirm the Diagnosis The diagnosis should be confirmed by the combination of the clinical presentation, the test results, and the response to the therapy. The diagnosis of the chlamydiosis should be confirmed by the positive PCR and the response to the antibiotic therapy. The diagnosis of the aspergillosis should be confirmed by the positive serology and the response to the antifungal therapy. ## Records and Measurements ### Record Keeping The records should include the clinical history, the physical examination findings, the diagnostic test results, and the treatment response. The records should be maintained for each bird and for the flock. The records should be used to monitor the disease status and to evaluate the effectiveness of the diagnostic approach. ### Measurement of the Diagnostic Accuracy The diagnostic accuracy should be measured by the sensitivity and the specificity of the test. The sensitivity is the proportion of the infected birds that test positive. The specificity is the proportion of the noninfected birds that test negative. The sensitivity and the specificity of the test should be considered when the test is selected. ### Monitoring the Treatment Response The treatment response should be monitored by the clinical improvement and the repeat testing. The repeat PCR should be performed after the treatment to confirm the elimination of the organism. The repeat serology should be performed after the treatment to monitor the antibody titer. ## Common Failure Patterns ### False Negative Results The false negative results can occur when the sample is collected at the wrong time, the sample is not collected correctly, or the test is not sensitive enough. The false negative results can also occur when the bird is in the early stage of the infection, and the antibody has not yet developed. ### False Positive Results The false positive results can occur when the test cross-reacts with other organisms, or the sample is contaminated. The false positive results can also occur when the bird has been exposed to the organism but is not actively infected. ### Sample Degradation The sample degradation can occur when the sample is not transported to the laboratory in a timely manner, or the sample is not stored at the appropriate temperature. The sample degradation can cause the false negative results. ### Interpretation Errors The interpretation errors can occur when the test results are not considered in the context of the clinical presentation. The positive serology result should not be interpreted as the active infection, and the positive PCR result should not be interpreted as the active infection. ## Welfare and Safety Context ### Zoonotic Risk Avian chlamydiosis is a zoonotic disease, and the infection can be transmitted from the birds to the humans. The transmission occurs through the inhalation of the aerosolized organisms from the respiratory secretions or the feces of the infected birds. The risk of the transmission is highest for the people who work with the birds, such as the veterinarians, the laboratory personnel, and the bird owners. The safety precautions should be taken when the birds are handled and the samples are collected. The gloves should be worn, and the hands should be washed after the handling. The birds should be handled in a well-ventilated area, and the respiratory protection should be worn when the aerosolization is possible. ### Welfare Considerations The diagnostic testing should be performed with the welfare of the bird in mind. The sample collection should be performed with the minimal stress and the pain. The bird should be handled gently, and the sample collection should be performed as quickly as possible. The treatment of the disease should be performed with the welfare of the bird in mind. The treatment should be administered according to the veterinary guidance, and the bird should be monitored for the adverse effects of the treatment. ## Professional Escalation Criteria ### Urgent Escalation The urgent escalation should be performed when the bird has a severe respiratory distress, the bird is unable to breathe, or the bird is in a critical condition. The bird should be referred to a veterinary emergency facility for the immediate treatment. ### Routine Escalation The routine escalation should be performed when the bird has a chronic respiratory disease, the bird is not responding to the treatment, or the bird has a suspected zoonotic disease. The bird should be referred to a veterinary specialist for the further diagnostic and the treatment. ### Reporting Requirements The reporting requirements should be followed when the avian chlamydiosis is suspected. The disease is a reportable disease in many jurisdictions, and the veterinarian should report the case to the appropriate authorities. The reporting requirements should be followed to prevent the spread of the disease to the other birds and to the humans. ## Building a Diagnostic Test Selection Matrix for Chronic and Atypical Presentations Veterinarians managing avian patients often face diagnostic uncertainty when clinical signs are subtle, intermittent, or atypical. The standard approach of selecting PCR for acute chlamydiosis and serology for chronic aspergillosis works well for classic presentations, but fails when the disease course does not match textbook patterns. A structured decision matrix that scores clinical findings, chronicity, and sample accessibility helps select the most appropriate test sequence and reduces the risk of false negatives that delay treatment. ### The Three Axis Decision Framework A practical framework for test selection uses three axes: chronicity, lesion location, and shedding probability. Each axis modifies the priority of PCR, serology, antigen detection, and culture. The framework is designed for use at the time of the initial physical examination, before laboratory submission, and it requires only information that is routinely gathered during a standard avian consultation. The chronicity axis distinguishes acute disease of less than 14 days, subacute disease of 14 to 42 days, and chronic disease beyond 42 days. This axis matters because antibody development in chlamydiosis typically requires 7 to 14 days, and the antibody response in aspergillosis develops over 2 to 4 weeks. Testing before these windows produces false negative serology results that can misdirect therapy. The lesion location axis separates upper respiratory signs, lower respiratory signs, and systemic signs. Upper respiratory signs include conjunctivitis, rhinitis, and sinusitis. Lower respiratory signs include dyspnea, abnormal lung sounds, and voice change. Systemic signs include weight loss, lethargy, and hepatomegaly. The lesion location directs the sample type because the organism or fungus concentrates at the site of pathology. The shedding probability axis estimates the likelihood that the bird is actively shedding organisms at the time of sampling. High shedding probability occurs in birds with acute onset, no prior antimicrobial therapy, and no prior antifungal therapy. Low shedding probability occurs in birds with chronic disease, prior therapy, or intermittent clinical signs. This axis determines whether PCR is likely to be informative or whether serology should be prioritized. ### Applying the Framework to Chlamydiosis For a bird with acute upper respiratory signs and high shedding probability, the framework directs PCR on conjunctival and choanal swabs as the first test. The [Merck Veterinary Manual](https://www.merckvetmanual.com/) notes that chlamydiosis in psittacine birds frequently presents with conjunctivitis and respiratory signs, and PCR on these samples provides the highest sensitivity for active shedding. For a bird with subacute signs and moderate shedding probability, the framework recommends PCR and serology submitted together. The PCR may still be positive if shedding continues, and the serology provides a baseline for paired testing. A second serology sample collected 2 to 4 weeks later confirms seroconversion, which is the most reliable serologic diagnosis. For a bird with chronic signs and low shedding probability, the framework prioritizes serology over PCR. The organism may be sequestered in tissues and shed intermittently, so a single PCR sample can produce a false negative result. The serology detects the antibody response that persists for months or years. The [World Organisation for Animal Health](https://www.woah.org/en/what-we-do/animal-health-and-welfare) notes that surveillance and reporting are important for this disease, and a positive serology in a chronic case supports the diagnosis even when PCR is negative. ### 3.1 The Chronic Chlamydiosis Diagnostic Sequence For chronic chlamydiosis, the framework recommends a sequence of three steps. First, collect serum for antibody testing. Second, collect conjunctival and choanal swabs for PCR on the same day. Third, if the serology is positive and the PCR is negative, repeat the PCR 7 to 14 days later to capture intermittent shedding. This sequence addresses the limitation that a single PCR sample may miss intermittent shedding. The repeat PCR increases the chance of detecting the organism during a shedding episode. The framework also recommends that the veterinarian document the antimicrobial history, because prior therapy with doxycycline or other tetracyclines can suppress shedding and produce false negative PCR results. ### 3.2 The Chronic Chlamydiosis Interpretation Table The following table provides a structured interpretation of combined serology and PCR results for chronic chlamydiosis. | Serology Result | PCR Result | Interpretation | Recommended Action | |-----------------|------------|----------------|---------------------| | Positive | Positive | Active or recent infection with shedding | Confirm with clinical signs, initiate treatment, report if required | | Positive | Negative | Prior exposure or latent infection | Repeat PCR in 7 to 14 days, consider paired serology | | Negative | Positive | Early infection before antibody development | Repeat serology in 2 to 4 weeks to confirm seroconversion | | Negative | Negative | Infection unlikely | Consider other differential diagnoses | This table is a clinical tool, not a substitute for laboratory interpretation. The veterinarian should consider the species, the clinical signs, and the history when applying the table. ### Applying the Framework to Aspergillosis The framework for aspergillosis uses the same three axes but with different test priorities. For acute aspergillosis with high shedding probability, the framework prioritizes PCR on a tracheal wash or air sac aspirate. The galactomannan antigen test can be used as an adjunct, but the sensitivity varies with the species and the stage of the disease. For chronic aspergillosis with low shedding probability, the framework prioritizes serology. The antibody response develops over 2 to 4 weeks and persists during the chronic phase. The serology is the most useful test for chronic disease, but it does not confirm the active infection. The framework requires the serology to be combined with radiography or endoscopy to confirm the presence of fungal lesions. ### 4.1 The Chronic Aspergillosis Diagnostic Sequence For chronic aspergillosis, the framework recommends a sequence of four steps. First, collect serum for antibody testing. Second, perform radiography of the respiratory tract to identify granulomas or air sac changes. Third, if a lesion is visible, collect a tracheal wash or air sac aspirate for PCR and culture. Fourth, if the serology is positive and the PCR is negative, the diagnosis is supported by the combination of the serology and the imaging findings. The framework also addresses the limitation of the galactomannan antigen test. The test is more sensitive in acute invasive disease than in chronic granulomatous disease. The framework recommends the galactomannan test only when the acute invasive form is suspected, and it should be interpreted with caution because false positives can occur with certain antibiotics. ### 3.2 The Aspergillosis Interpretation Table The following table provides a structured interpretation for the combination of serology, PCR, and imaging in aspergillosis. | Serology Result | PCR Result | Imaging Finding | Interpretation | Action | |-----------------|------------|-----------------|---------------------|--------| | Positive | Positive | Lesion present | Active fungal infection | Initiate antifungal therapy | | Positive | Negative | Lesion present | Chronic infection with low fungal load | Initiate antifungal therapy based on imaging | | Positive | Negative | No lesion | Prior exposure or environmental exposure | Consider alternative causes, monitor | | Negative | Positive | Lesion present | Early infection or localized disease | Confirm with culture, initiate antifungal therapy | | Negative | Negative | Lesion present | Consider other causes of the lesion | Biopsy the lesion for histopathology | The table is a decision aid for the veterinarian. The final diagnosis is based on the combination of the clinical presentation, the test results, and the response to therapy. ### The Framework in Practice The framework is designed to be used at the time of the clinical examination. The veterinarian assesses the three axes, selects the test sequence, and records the results. The framework is not a replacement for clinical judgment, but it provides a structured approach that reduces the risk of a single test being misinterpreted. ### Step 1: Record the Chronicity The veterinarian records the duration of the clinical signs. The duration is classified as acute, subacute, or chronic. The classification determines whether the antibody response has had time to develop and whether the organism is likely to be actively shedding. ### Step 2: Record the Lesion Location The veterinarian records the lesion location as upper respiratory, lower respiratory, or systemic. The location directs the sample choice. For upper respiratory signs, the conjunctival and choanal swabs are the preferred samples. For lower respiratory signs, the tracheal wash or air sac aspirate is the preferred sample. ### Step 3: Estimate the Shedding Probability The veterinarian estimates the shedding probability based on the onset, the prior therapy, and the clinical signs. The estimate is recorded as high, moderate, or low. The estimate determines whether the PCR is likely to be informative. ### Step 4: Select the Test Sequence The veterinarian selects the test sequence based on the three recorded factors. The sequence is recorded in the medical record. The sequence is used to guide the sample collection and the laboratory submission. ### Step 5: Interpret the Results The veterinarian interprets the results using the interpretation tables. The interpretation is recorded in the medical record. The interpretation is used to guide the treatment and the follow-up testing. ### Step 6: Monitor the Response The veterinarian monitors the response to the treatment. The response is monitored by the clinical improvement and the repeat testing. The repeat PCR is performed after the treatment to confirm the elimination of the organism. The repeat serology is performed after the treatment to monitor the antibody titer. ### Common Failure Patterns in the Framework The framework has several common failure patterns that the veterinarian should recognize. The first failure pattern is the collection of a single PCR sample in a bird with chronic disease. The single sample can be negative because the shedding is intermittent. The framework addresses this by recommending the repeat PCR. The second failure pattern is the interpretation of a positive serology as an active infection. The positive serology indicates the exposure, not the active infection. The framework addresses this by requiring the combination of the serology and the PCR or the imaging. The third failure pattern is the collection of the sample after the initiation of the therapy. The antimicrobial therapy can reduce the shedding and cause the false negative PCR. The antifungal therapy can reduce the fungal load and cause the false negative PCR. The framework addresses this by requiring the sample collection before the therapy. The fourth failure pattern is the use of the galactomannan antigen test for the chronic granulomatous disease. The test is less sensitive for the chronic form. The framework addresses this by recommending the test only for the acute invasive form. ### The Framework and the Zoonotic Risk The framework also considers the zoonotic risk of chlamydiosis. The [American Veterinary Medical Association](https://www.avma.org/resources-tools/pet-owners) provides general guidance for pet owners and veterinarians on the prevention of zoonotic disease. The veterinarian should use the framework to confirm the diagnosis of chlamydiosis as early as possible, because the early diagnosis reduces the risk of the transmission to the humans. The framework also considers the welfare of the bird. The sample collection should be performed with the minimal stress and the pain. The bird should be handled gently, and the sample collection should be performed as quickly as possible. The framework is designed to minimize the number of the samples by selecting the most appropriate test for the clinical presentation. ### The Framework and the Reporting Requirements The framework also addresses the reporting requirements. The avian chlamydiosis is a reportable disease in many jurisdictions. The veterinarian should report the case to the appropriate authorities when the disease is suspected. The reporting requirements are followed to prevent the spread of the disease to the other birds and to the humans. The [World Organisation for Animal Health](https://www.woah.org/en/what-we-do/animal-health-and-welfare) provides the official guidance on the animal health surveillance and the reporting. ### The Framework and the Global Guidelines The framework is consistent with the global guidelines for the companion-animal practice. The [World Small Animal Veterinary Association](https://wsava.org/global-guidelines) provides the global guidelines for the clinical practice. The framework is a practical application of the guidelines for the avian patient. The framework is also consistent with the [American Animal Hospital Association](https://www.aaha.org/resources) guidelines for the preventive care and the practice guidance. The framework is a structured approach that can be incorporated into the practice protocols. ### The Framework and the University Resources The framework is supported by the university veterinary education resources. The [Cornell University College of Veterinary Medicine](https://www.vet.cornell.edu/) provides the veterinary education and the animal health resources. The framework is a practical application of the veterinary education principles. ### The Framework and the Owner Communication The framework also supports the owner communication. The veterinarian can use the framework to explain the diagnostic approach to the owner. The owner can understand the reason for the test selection and the interpretation of the results. The owner can also understand the zoonotic risk and the reporting requirements. The framework is a practical tool for the veterinarian. It is a structured approach to the diagnostic testing for the avian chlamydiosis and the aspergillosis. The framework is based on the clinical presentation, the chronicity, and the shedding probability. The framework is designed to reduce the risk of the false negative results and the misinterpretation of the test results. The framework is a valuable addition to the diagnostic approach for these two diseases. ## Frequently Asked Questions ### What is the most sensitive test for avian chlamydiosis? PCR testing on conjunctival or choanal swabs provides the highest sensitivity for detecting active shedding of *Chlamydia psittaci*. The test detects the DNA of the organism and is most reliable during the acute phase of infection when the bird is actively shedding. ### When should serology be used for avian chlamydiosis? Serology is most useful for detecting chronic or latent infections where the organism is not actively shedding. The test detects antibodies that persist after exposure, so a positive result indicates prior exposure but does not confirm an active infection. ### What is the best test for chronic aspergillosis? Serology is the most useful test for chronic aspergillosis because the antibody response develops over weeks and persists during the chronic phase. The test should be combined with radiography or imaging to confirm the presence of fungal lesions. ### Can PCR detect aspergillosis in birds? PCR can detect the DNA of *Aspergillus* species in tracheal washes, air sac swabs, or blood samples. The test is most reliable in birds with active fungal growth and less sensitive in chronic granulomatous disease. ### How long does it take to get PCR results for chlamydiosis? PCR results are typically available within 24 to 48 hours after the laboratory receives the sample. The turnaround time depends on the laboratory and the shipping time. ### What sample should be collected for chlamydiosis testing? Conjunctival and choanal swabs are the preferred samples for chlamydiosis testing. The swabs should be collected before the initiation of antibiotic therapy to avoid false negative results. ### What is the galactomannan antigen test for aspergillosis? The galactomannan antigen test detects a component of the fungal cell wall in the serum. The test is useful for invasive aspergillosis but is less sensitive for chronic granulomatous disease. ### Can a bird test positive for chlamydiosis without being sick? Yes, a bird can test positive for chlamydiosis without showing clinical signs. The PCR can detect the DNA of the organism in a bird that is shedding but not sick, and the serology can detect the antibody in a bird that has been exposed but is not actively infected. ## Related Veterinary Guides - [Zoonotic Disease Diagnostic Testing: Sensitivity, Specificity, and Interpretation](/knowledge/veterinary-medicine/veterinary-public-health/zoonotic-disease-diagnostic-testing-sensitivity-specificity-interpretation) - [Diagnostic Test Evaluation: Sensitivity and Specificity in Veterinary Medicine](/knowledge/veterinary-medicine/veterinary-epidemiology/diagnostic-test-evaluation-sensitivity-specificity-veterinary-medicine) - [Avian Diagnostic Imaging: Radiography and Ultrasonography in Birds](/knowledge/veterinary-medicine/backyard-poultry/avian-diagnostic-imaging-radiography-ultrasonography-birds) - [Avian Anesthesia: Monitoring and Troubleshooting in Pet Birds](/knowledge/veterinary-medicine/anesthesia-analgesia/avian-anesthesia-monitoring-troubleshooting-pet-birds) - [Signs of Illness in Pet Birds and When to See an Avian Vet](/knowledge/veterinary-medicine/pet-bird-care/pet-bird-illness-signs) ## References and Further Reading - [Pet Care](https://www.avma.org/resources-tools/pet-owners). American Veterinary Medical Association. - [AAHA Guidelines](https://www.aaha.org/resources). American Animal Hospital Association. - [Global Guidelines](https://wsava.org/global-guidelines). World Small Animal Veterinary Association. - [Merck Veterinary Manual](https://www.merckvetmanual.com/). Merck Veterinary Manual. - [Cornell University College of Veterinary Medicine](https://www.vet.cornell.edu/). Cornell University. - [Animal Health and Welfare](https://www.woah.org/en/what-we-do/animal-health-and-welfare). World Organisation for Animal Health. - [Health evaluation of free-ranging and hand-reared macaws (Ara spp.) in Peru.](https://pubmed.ncbi.nlm.nih.gov/9523629). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 1997. - [Diagnostic value of serum amyloid A in differentiating the inflammatory disorders in wild birds.](https://doi.org/10.3389/fvets.2024.1284113). 2024. - [Avian Malaria in Penguins: Diagnostics and Future Direction in the Context of Climate Change.](https://doi.org/10.3390/ani12050600). 2022. - [A Survey of Diseases in Different Species of Wild, Captive, and Illegally Traded Birds in Brazil.](https://doi.org/10.3390/ani14010025). 2023. - [Baseline health parameters of rhinoceros auklets (Cerorhinca monocerata) using serum protein electrophoresis, acute phase proteins, and biochemistry.](https://doi.org/10.3389/fvets.2024.1379980). 2024. > This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.